Dual Responder Analyses of Both Muscle Strength and Activities of Daily Living, Eculizumab Versus Placebo, in Refractory Generalized Myasthenia Gravis (gMG) Patients: Results from the REGAIN Study

被引：0
|
作者：
Howard, James
O'Brien, Fanny
Wang, Jing Jing
Mantegazza, Renato
机构：
来源：
NEUROLOGY | 2017年 / 89卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E101 / E102
页数：2
相关论文
共 11 条
  • [1] Correlation of assessments of activities of daily living and muscle strength in refractory myasthenia gravis in the REGAIN study
    Vissing, J.
    Zhang, J.
    Derosier, F.
    Wang, J. J.
    Howard, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 584 - 585
  • [2] Eculizumab improves fatigue in patients with refractory generalized myasthenia gravis in the REGAIN study
    Andersen, H.
    Mantegazza, R.
    Derosier, F.
    Wang, J. J.
    Zhang, J.
    Howard, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 498 - 498
  • [3] Myasthenia Gravis Activities of Daily Living (MG-ADL) Response to Eculizumab Treatment in Patients from the Generalized Myasthenia Gravis Registry
    Greene, Ericka
    Cutter, Gary
    Muppidi, Srikanth
    Juel, Vern
    Rodrigues, Ema
    Korideck, Houari
    Howard, James, Jr.
    [J]. NEUROLOGY, 2023, 100 (17)
  • [4] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER, MULTICENTER, PHASE II STUDY OF ECULIZUMAB IN PATIENTS WITH REFRACTORY GENERALIZED MYASTHENIA GRAVIS (GMG)
    Howard, J. F.
    Barohn, R.
    Cutter, G.
    Freimer, M.
    Juel, V.
    Mozaffar, T.
    Mellion, M.
    Benatar, M.
    Farragia, M.
    Pulley, M.
    Gorson, K.
    Chaudry, V.
    Pascuzzi, R.
    Siddiqi, Z.
    Kissell, J. T.
    [J]. MUSCLE & NERVE, 2011, 44 (04) : 689 - 690
  • [5] Randomized, Double-Blind, Placebo-Controlled, Crossover, Multicenter, Phase II Study of Eculizumab in Patients with Refractory Generalized Myasthenia Gravis (gMG)
    Howard, James
    Barohn, Richard
    Freimer, Miriam
    Juel, Vern
    Mozaffar, Tahseen
    Mellion, Michelle
    Benatar, Michael
    Farrugia, Maria
    Kissel, John
    [J]. NEUROLOGY, 2012, 78
  • [6] Open label extension trial of regain to evaluate the safety and efficacy of eculizumab in patients from japan with refractory generalized myasthenia gravis
    Murai, H.
    Uzawa, A.
    Suzuki, Y.
    Imai, T.
    Shiraishi, H.
    Tsuda, E.
    Suzuki, H.
    Okumura, M.
    Utsugisawa, K.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 132 - 133
  • [7] A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
    Howard, James F., Jr.
    Barohn, Richard J.
    Cutter, Gary R.
    Freimer, Miriam
    Juel, Vern C.
    Mozaffar, Tahseen
    Mellion, Michelle L.
    Benatar, Michael G.
    Farrugia, Maria Elena
    Wang, Jing Jing
    Malhotra, Suneil S.
    Kissel, John T.
    [J]. MUSCLE & NERVE, 2013, 48 (01) : 76 - 84
  • [8] CORRELATION BETWEEN MYASTHENIA GRAVIS-ACTIVITIES OF DAILY LIVING (MG-ADL) AND QUANTITATIVE MYASTHENIA GRAVIS (QMG) ASSESSMENTS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE REFRACTORY GENERALIZED MYASTHENIA GRAVIS IN THE PHASE 3 REGAIN STUDY
    Vissing, John
    O'Brien, Fanny
    Wang, Jing Jing
    Howard, James F., Jr.
    [J]. MUSCLE & NERVE, 2018, 58 (02) : E21 - E22
  • [9] REAL-WORLD EFFECTIVENESS OF ECULIZUMAB IN BLACK PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS IN THE US: RESULTS FROM A RETROSPECTIVE OBSERVATIONAL STUDY
    Morgan, Marla
    Habib, Ali A.
    Nowak, Richard J.
    Muppidi, Srikanth
    Parthan, Anju
    Kielhorn, Adrian
    Wang, Jane
    Howard, James F., Jr.
    [J]. MUSCLE & NERVE, 2022, 66 : S126 - S126
  • [10] Donepezil preserves activities of daily living in Alzheimer's disease patients: Results from a one year placebo controlled functional survival study
    Mohs, R
    Doody, R
    Morris, J
    Ieni, J
    Perdomo, C
    Pratt, R
    Rogers, S
    [J]. NEUROLOGY, 2000, 54 (07) : A415 - A415
12